How 30 minutes of daily activity can lower blood sugar and reduce medication dependence
Walking is often underestimated. It improves circulation, helps muscles absorb glucose, and reduces stress. But doing only one…
Ozempic just got cheap enough to change the world
By now, Ozempic needs no introduction in America. One in 8 American adults now takes a GLP-1 drug…
Metformin boosts an exercise-linked metabolite and may help control weight in prostate cancer patients
A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe…
6 drugs invented for one thing — but now treat another
Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if…
Evolocumab trial could reshape how doctors treat high-risk cholesterol patients
A major cholesterol guideline arrived just as pivotal new trial data emerged, revealing how fast-moving evidence could soon…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
Surge of generic weight-loss drugs triggers price war in India
Open this photo in gallery: Obesity doctor and consultant Swati Pradhan explains the Mounjaro GLP-1 self-injectable device at…
Short Bursts of Exercise Lower Disease Risk
As it turns out, you don’t need long workouts to improve your health. Just a few minutes of…
American Heart Association’s 9 diet rules to lower heart disease risk
From childhood to adulthood, the AHA’s latest guidance shows how consistent, real-world food choices, not fad diets or…
All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
Fiber supplement stabilizes blood sugar in gestational diabetes
A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births…
Lifestyle care in primary clinics allows for safe diabetes deprescribing
A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe when patients…